Structural and functional neuroimaging in human prion diseases;Neuroimagen estructural y funcional en las enfermedades priónicas humanas

Neurologia

Volumn 28, Issue 5, 2013, Pages 299-308

  Ortega Cubero, S ^a   Luquin M R ^a   Dominguez I ^a   Arbizu, J ^a   Pagola, I ^a   Carmona Abellan M M ^a   Riverol, M ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Creutzfeldt Jakob; MRI; PET; Prion; Prion diseases; SPECT

Indexed keywords

CREUTZFELDT JAKOB DISEASE; ELECTROENCEPHALOGRAM; FUNCTIONAL NEUROIMAGING; HISTOPATHOLOGY; HUMAN; IATROGENIC DISEASE; KURU; NUCLEAR MAGNETIC RESONANCE IMAGING; PRION DISEASE; PROTEIN CEREBROSPINAL FLUID LEVEL; PULVINAR; SHORT SURVEY;

14-3-3 PROTEINS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; ELECTROENCEPHALOGRAPHY; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; HUMANS; INSOMNIA, FATAL FAMILIAL; KURU; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; PRION DISEASES; PRPC PROTEINS;

EID: 84878491160     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2011.03.012     Document Type: Short Survey

References (80)

1. Hill A.F., Joiner S., Wadsworth J.D., Sidle K.C., Bell J.E., Budka H., et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003, 126:1333-1346.
2. Stahl N., Borchelt D.R., Hsiao K., Prusiner S.B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987, 51:229-240.
3. Prusiner S.B., Scott M.R., DeArmond S.J., Cohen F.E. Prion protein biology. Cell 1998, 93:337-348.
4. Chesebro B., Race R., Wehrly K., Nishio J., Bloom M., Lechner D., et al. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 1985, 315:331-333.
5. Steele A.D., Emsley J.G., Ozdinler P.H., Lindquist S., Macklis J.D. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci USA 2006, 103:3416-3421.
6. Zhang C.C., Steele A.D., Lindquist S., Lodish H.F. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc Natl Acad Sci USA 2006, 103:2184-2189.
7. Cashman N.R., Loertscher R., Nalbantoglu J., Shaw I., Kascsak R.J., Bolton D.C., et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 1990, 61:185-192.
8. Chiarini L.B., Freitas A.R., Zanata S.M., Brentani R.R., Martins V.R., Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J 2002, 21:3317-3326.
9. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., et al. Signal transduction through prion protein. Science 2000, 289:1925-1928.
10. Maglio L.E., Pérez M.F., Martins V.R., Brentani R.R., Ramírez O.A. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 2004, 131:58-64.
11. Brown D.R., Sassoon J. Copper-dependent functions for the prion protein. Mol Biotechnol 2002, 22:165-178.
12. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992, 356:577-582.
13. Prusiner S.B., Scott M., Foster D., Pan K.M., Groth D., Mirenda C., et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990, 63:673-686.
14. Westergard L., Christensen H.M., Harris D.A. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007, 1772:629-644.
15. Collins S., McLean C.A., Masters C.L. Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci 2001, 8:387-397.
16. Mead S., Whitfield J., Poulter M., Shah P., Uphill J., Campbell T., et al. A novel protective prion protein variant that colocalizes with kuru exposure. N Engl J Med 2009, 361:2056-2065.
17. Duffy P., Wolf J., Collins G., DeVoe A.G., Streeten B., Cowen D. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974, 290:692-693.
18. Brown P. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Haemophilia 2007, 13Suppl5:S33-40.
19. Meissner B., Kallenberg K., Sánchez-Juan P., Ramljak S., Krasnianski A., Heinemann U., et al. MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease. J Neurol 2009, 256:355-363.
20. Sánchez-Juan P., Green A., Ladogana A., Cuadrado-Corrales N., Sánchez-Valle R., Mitrovaa E., et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006, 67:637-643.
21. Wieser H.G., Schindler K., Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol 2006, 117:935-951.
22. Rabinstein A.A., Whiteman M.L., Shebert R.T. Abnormal diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease following corneal transplantations. Arch Neurol 2002, 59:637-639.
23. Lewis A.M., Yu M., DeArmond S.J., Dillon W.P., Miller B.L., Geschwind M.D. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. Arch Neurol 2006, 63:288-290.
24. Oppenheim C., Zuber M., Galanaud D., Detilleux M., Bolgert F., Mas J.L., et al. Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2004, 75:1066-1069.
25. Hill A.F., Desbruslais M., Joiner S., Sidle K.C., Gowland I., Collinge J., et al. The same prion strain causes vCJD and BSE. Nature 1997, 389:448-450. 526.
26. Riverol M, Palma JA, Alana M, Guerrero-Márquez C, Luquín MR, Rábano A. Variant Creutzfeldt-Jakob disease occurring in mother and son. J Neurol Neurosurg Psychiatry. 2011 Feb 22. [Epub ahead of print].
27. Will R.G., Zeidler M., Stewart G.E., Macleod M.A., Ironside J.W., Cousens S.N., et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000, 47:575-582.
28. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996, 347:921-925.
29. Collie D.A., Summers D.M., Sellar R.J., Ironside J.W., Cooper S., Zeidler M., et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 2003, 24:1560-1569.
30. Heath CA, Cooper SA, Murray K, Lowman A, Henry C, MacLeod MA, et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol. 2010;67:761-70.
31. Soares-Fernandes J.P., Ribeiro M., Machado A. 'Hot cross bun' sign in variant Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2009, 30:E37.
32. De la Torre Laviana F.J. Bilateral hyperintensity of the pulvinar in sporadic Creutzfeldt-Jakob disease. Neurologia 2009, 24:202-208.
33. Hahn J.S., Sum J.M., Lee K.P. Unusual MRI findings after status epilepticus due to cat-scratch disease. Pediatr Neurol 1994, 10:255-258.
34. Harding B.N., Alsanjari N., Smith S.J., Wiles C.M., Thrush D., Miller D.H., et al. Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults. J Neurol Neurosurg Psychiatry 1995, 58:320-325.
35. Mihara M., Sugase S., Konaka K., Sugai F., Sato T., Yamamoto Y., et al. The "pulvinar sign" in a case of paraneoplastic limbic encephalitis associated with non-Hodgkin's lymphoma. J Neurol Neurosurg Psychiatry 2005, 76:882-884.
36. Cusmai R., Bertini E., Di Capua M., Ricci S., Vigevano F., Milani L., et al. Bilateral, reversible, selective thalamic involvement demonstrated by brain MR and acute severe neurological dysfunction with favorable outcome. Neuropediatrics 1994, 25:44-47.
37. De Silva R., Patterson J., Hadley D., Russell A., Turner M., Zeidler M. Single photon emission computed tomography in the identification of new variant Creutzfeldt-Jakob disease: case reports. BMJ 1998, 316:593-594.
38. Cordery R.J., MacManus D., Godbolt A., Rossor M.N., Waldman A.D. Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. Eur Radiol 2006, 16:1692-1698.
39. Schroter A., Zerr I., Henkel K., Tschampa H.J., Finkenstaedt M., Poser S. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000, 57:1751-1757.
40. Young G.S., Geschwind M.D., Fischbein N.J., Martindale J.L., Henry R.G., Liu S., et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005, 26:1551-1562.
41. Meissner B., Kallenberg K., Sánchez-Juan P., Krasnianski A., Heinemann U., Varges D., et al. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2008, 29:1519-1524.
42. Tschampa H.J., Kallenberg K., Urbach H., Meissner B., Nicolay C., Kretzschmar H.A., et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005, 128:2026-2033.
43. Lodi R., Parchi P., Tonon C., Manners D., Capellari S., Strammiello R., et al. Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain 2009, 132:2669-2679.
44. Meissner B., Kallenberg K., Sánchez-Juan P., Collie D., Summers D.M., Almonti S., et al. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 2009, 72:1994-2001.
45. Zerr I., Schulz-Schaeffer W.J., Giese A., Bodemer M., Schroter A., Henkel K., et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000, 48:323-329.
46. Steinhoff B.J., Zerr I., Glatting M., Schulz-Schaeffer W., Poser S., Kretzschmar H.A. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 2004, 56:702-708.
47. Zerr I., Kallenberg K., Summers D.M., Romero C., Taratuto A., Heinemann U., et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009, 132:2659-2668.
48. Gorniak R.J., Young G.S., Wiese D.E., Marty F.M., Schwartz R.B. MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogeneic hematopoietic stem-cell transplantation. AJNR Am J Neuroradiol 2006, 27:887-891.
49. Kuker W., Nagele T., Schmidt F., Heckl S., Herrlinger U. Diffusion-weighted MRI in herpes simplex encephalitis: a report of three cases. Neuroradiology 2004, 46:122-125.
50. Dale R.C., Church A.J., Heyman I. Striatal encephalitis after varicella zoster infection complicated by Tourettism. Mov Disord 2003, 18:1554-1556.
51. Arbelaez A., Castillo M., Mukherji S.K. Diffusion-weighted MR imaging of global cerebral anoxia. AJNR Am J Neuroradiol 1999, 20:999-1007.
52. Calistri V., Caramia F., Bianco F., Fattapposta F., Pauri F., Bozzao L. Visualization of evolving status epilepticus with diffusion and perfusion MR imaging. AJNR Am J Neuroradiol 2003, 24:671-673.
53. O'Donnell P., Buxton P.J., Pitkin A., Jarvis L.J. The magnetic resonance imaging appearances of the brain in acute carbon monoxide poisoning. Clin Radiol 2000, 55:273-280.
54. Saatci I., Topcu M., Baltaoglu F.F., Kose G., Yalaz K., Renda Y., et al. Cranial MR findings in Wilson's disease. Acta Radiol 1997, 38:250-258.
55. Barkovich A.J., Good W.V., Koch T.K., Berg B.O. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993, 14:1119-1137.
56. Mukherjee P., McKinstry R.C. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001, 219:756-765.
57. Heinemann U., Krasnianski A., Meissner B., Varges D., Kallenberg K., Schulz-Schaeffer W.J., et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 2007, 130:1350-1359.
58. Mittal S., Farmer P., Kalina P., Kingsley P.B., Halperin J. Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol 2002, 59:128-134.
59. Parchi P., Giese A., Capellari S., Brown P., Schulz-Schaeffer W., Windl O., et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999, 46:224-233.
60. Kropp S., Schulz-Schaeffer W.J., Finkenstaedt M., Riedemann C., Windl O., Steinhoff B.J., et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol 1999, 56:55-61.
61. Castellani R.J., Colucci M., Xie Z., Zou W., Li C., Parchi P., et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004, 63:436-442.
62. Krasnianski A., Meissner B., Schulz-Schaeffer W., Kallenberg K., Bartl M., Heinemann U., et al. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2006, 63:876-880.
63. Krasnianski A., Schulz-Schaeffer W.J., Kallenberg K., Meissner B., Collie D.A., Roeber S., et al. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. Brain 2006, 129:2288-2296.
64. Hamaguchi T., Kitamoto T., Sato T., Mizusawa H., Nakamura Y., Noguchi M., et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology 2005, 64:643-648.
65. Barash J.A. Clinical features of sporadic fatal insomnia. Rev Neurol Dis 2009, 6:E87-93.
66. Parchi P., Capellari S., Chin S., Schwarz H.B., Schecter N.P., Butts J.D., et al. A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology 1999, 52:1757-1763.
67. Perani D., Cortelli P., Lucignani G., Montagna P., Tinuper P., Gallassi R., et al. [18F]FDG PET in fatal familial insomnia: the functional effects of thalamic lesions. Neurology 1993, 43:2565-2569.
68. Meissner B., Westner I.M., Kallenberg K., Krasnianski A., Bartl M., Varges D., et al. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005, 65:1544-1550.
69. Henkel K., Zerr I., Hertel A., Gratz K.F., Schroter A., Tschampa H.J., et al. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol 2002, 249:699-705.
70. Fulbright R.K., Hoffmann C., Lee H., Pozamantir A., Chapman J., Prohovnik I. MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 2008, 29:1638-1643.
71. Renard D., Collombier L., Castelnovo G., Remy A., Laplanche J.L., Labauge P. Fluorine 18-labeled fluorodeoxyglucose positron emission tomography in familial Creutzfeldt-Jakob disease. Arch Neurol 2008, 65:1390-1391.
72. Konno S., Murata M., Toda T., Yoshii Y., Nakazora H., Nomoto N., et al. Familial Creutzfeldt-Jakob Disease with a codon 200 mutation presenting as thalamic syndrome: diagnosis by single photon emission computed tomography using (99m)Tc-ethyl cysteinate dimer. Intern Med 2008, 47:65-67.
73. Waldman A.D., Cordery R.J., MacManus D.G., Godbolt A., Collinge J., Rossor M.N. Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy. Neuroradiology 2006, 48:428-433.
74. Chi NF, Lee YC, Lu YC, Wu HM, Soong BW. Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes: clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan. J Neurol. 2010:257:191-7..
75. Konaka K., Kaido M., Okuda Y., Aoike F., Abe K., Kitamoto T., et al. Proton magnetic resonance spectroscopy of a patient with Gerstmann-Straussler-Scheinker disease. Neuroradiology 2000, 42:662-665.
76. Kepe V., Ghetti B., Farlow M.R., Bresjanac M., Miller K., Huang S.C., et al. PET of Brain Prion Protein Amyloid in Gerstmann-Straussler-Scheinker Disease. Brain Pathol 2010, 20:419-430.
77. Okamura N., Shiga Y., Furumoto S., Tashiro M., Tsuboi Y., Furukawa K., et al. In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET. Eur J Nucl Med Mol Imaging 2010, 37:934-941.
78. Arata H., Takashima H., Hirano R., Tomimitsu H., Machigashira K., Izumi K., et al. Early clinical signs and imaging findings in Gerstmann-Straussler-Scheinker syndrome (Pro102Leu). Neurology 2006, 66:1672-1678.
79. Zerr I., Giese A., Windl O., Kropp S., Schulz-Schaeffer W., Riedemann C., et al. Phenotypic variability in fatal familial insomnia (D178N-129M) genotype. Neurology 1998, 51:1398-1405.
80. Johnson M.D., Vnencak-Jones C.L., McLean M.J. Fatal familial insomnia: clinical and pathologic heterogeneity in genetic half brothers. Neurology 1998, 51:1715-1717.